ENT Surgical Devices and Equipment Market:
WiseGuyReports.com adds “Global ENT Surgical Devices and Equipment Market Research Report 2020 Analysis and Forecast 2030” reports to its database.
Executive Summary
The ENT surgical devices and equipment market consists of sales of ENT (ear-nose-throat) surgical devices. ENT surgical devices include balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes and handheld instruments are used to perform surgical procedures such as tonsillectomy, tracheostomy, implantations, septorhinoplasty, turbinate reduction, mastoidectomy, stapedectomy and reconstruction surgeries. Based on the mode of operation, this market is segmented into hand-held devices, portable devices and fixed devices.
The global ent surgical devices and equipment market is expected to decline from $1.7 billion in 2019 to $1.3 billion in 2020 at a compound annual growth rate (CAGR) of -20.8%. The decline is mainly because of worldwide supply and demand mismatches of resources due to the COVID-19 outbreak. There is an inadequate production of hearing implants, hearing aid, hearing diagnostic, voice prosthesis, and other ENT-related devices due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 3.6% from 2021 and reach $1.9 billion in 2023.
Get Sample Copy of the Report @ https://www.wiseguyreports.com/sample-request/6004309-ent-surgical-devices-and-equipment-global-market-report
North America was the largest region in the ENT surgical devices and equipment market in 2018. This region is expected to remain the largest during the next five years. The ENT surgical devices and equipment market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offers patients with many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In majority of the cases physicians enjoy higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market.
Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market. ENT surgical procedures are complex, involves greater devices and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market.
ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries. It involves less tissue damage, reduced scarring and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted.
The ENT surgical devices and equipment industry has lately witnessed a rise in number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by FDA in November 2018, the FDA 510(K) is expected to see number of updates in order to regulate safety, technology, and capabilities in the medical devices space. In 2017, the European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management.
In February 2018, Stryker Corporation, a medical technology company acquired Entellus Medical, Inc. for $664 million. With this acquisition, it is expected to consolidate Stryker’s position in the ENT surgical devices market with a firm grip on minimally invasive surgeries. Entellus Medical, Inc., a US-based company involved in the manufacturing of ENT surgical devices for minimally invasive treatment of patients suffering from various ENT diseases.
Major players in the market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd., KLS Martin LP, Acclarent, Inc.
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/reports/6004309-ent-surgical-devices-and-equipment-global-market-report
NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.